As for our concerned lncRNA, HOXA11-AS also predicted poor prognosis in NSCLC, which could promote cell epithelial–mesenchymal transition by inhibiting miR-200b expression in NSCLC [40]. The gene discussed is HOXA11; the disease is non-small cell lung carcinoma.